Xuanfei Li

机构：Wuhan University, Zhongnan Hospital of Wuhan University, Hubei Cancer Hospital · ORCID：0000-0002-8560-0608

发表论文 24 篇 · 总被引 319 次 · h-index 11

代表论文

• Pre-conditioning with tanshinone IIA attenuates the ischemia/reperfusion injury caused by liver grafts via regulation of HMGB1 in rat Kupffer cells (2017 · Biomedicine & Pharmacotherapy · 被引 45)
• Nobiletin attenuates lipopolysaccharide/D-galactosamine-induced liver injury in mice by activating the Nrf2 antioxidant pathway and subsequently inhibiting NF-κB-mediated cytokine production (2016 · Molecular Medicine Reports · 被引 38)
• Ultrasound-targeted microbubble destruction-mediated downregulation of CD133 inhibits epithelial-mesenchymal transition, stemness and migratory ability of liver cancer stem cells (2015 · Oncology Reports · 被引 34)
• Agmatine Protects against Zymosan-Induced Acute Lung Injury in Mice by Inhibiting NF- κ B-Mediated Inflammatory Response (2014 · BioMed Research International · 被引 27)
• DNMBP-AS1 Regulates NHLRC3 Expression by Sponging miR-93-5p/17-5p to Inhibit Colon Cancer Progression (2022 · Frontiers in Oncology · 被引 26)
• Lidocaine alleviates cisplatin resistance and inhibits migration of MGC-803/DDP cells through decreasing miR-10b (2020 · Cell Cycle · 被引 22)